Ixekizumab Eases Pain and Fatigue, Improves AS Patients’ Quality of Life, Phase 3 Trials Show
Under-the-skin treatment with ixekizumab leads to early and sustained reductions in pain, fatigue, and inflammation, as well as significant improvements in sleep and quality of life, as reported by patients with ankylosing spondylitis (AS) who took part in two Phase 3 trials. The research, “Translating Improvements…